Fidelity Investments
KMTS

Fidelity Investments’s Kestra Medical Technologies KMTS Stock Holding History

Fidelity Investments’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114M Sell
5,721,054
-130,590
-2% -$3.08M 0.01% 1113
2025
Q4 		$155M Buy
5,851,644
+573,656
+11% +$14.8M 0.01% 979
2025
Q3 		$125M Buy
5,277,988
+1,582,693
+43% +$28.3M 0.01% 1075
2025
Q2 		$61.3M Buy
3,695,295
+496,251
+16% +$10.8M ﹤0.01% 1316
2025
Q1 		$79.7M Buy
+3,199,044
New +$73.5M 0.01% 1180

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments's KMTS Position: Q1 2026 in Review

Fidelity Investments reduced its Kestra Medical Technologies (KMTS) stake by 2.2% in Q1 2026, selling an estimated $3.08M and leaving 5,721,054 shares worth $114M. The position accounts for 0.01% of the portfolio, ranked #1113.

Fidelity Investments first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $155M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Fidelity Investments held 5,721,054 shares of Kestra Medical Technologies worth $114M as of Q1 2026.
  • Fidelity Investments sold 130,590 Kestra Medical Technologies shares in Q1 2026, an estimated $3.08M.
  • Kestra Medical Technologies made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #1113 holding.
  • Fidelity Investments first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Fidelity Investments's Kestra Medical Technologies position peaked at $155M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.